Meanwhile, the activity of EZH2 in Treg cells maintains the stability of FOXP3 protein, increases the number of tumor-infiltrating FOXP3+ Tregs, alters the homeostatic balance with tumor effector T cells in the microenvironment and impairs the anti-tumor immune response (29). Here, EZH2 is linked to neoplasm.